TORSEMIDE Side Effects

6442317-5 | Eosinophil Count Increased, Pruritus
on Oct 28, 2009 Male patient from , 88 years of age, was diagnosed with oedema peripheral and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophil count increased, pruritus. Torsemide dosage: 4 Mg (4 Mg, 1 In 1 D), Oral. During the same period patient was treated with CARDENALIN (DOXAZOSIN MESYLATE) (View Cardenalin (doxazosin Mesylate) Review and Cardenalin (doxazosin Mesylate) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6438234-7 | Blood Pressure Increased, Cerebral Haemorrhage, Chest Pain, Inappropriate Antidiuretic Hormone Secretion, Osteochondrosis, Spinal Osteoarthritis, Spondylolysis, Syncope
Patient was taking Torsemide (View Usage). Patient had the following side effects: blood pressure increased, cerebral haemorrhage, chest pain (What is chest pain?), inappropriate antidiuretic hormone secretion, osteochondrosis, spinal osteoarthritis, spondylolysis, syncope on Oct 26, 2009 from Additional patient health information: Female patient , 80 years of age, weighting 220.5 lb, was diagnosed with hypertension and. Torsemide dosage: 2.5 Mg (2.5 Mg, 1 In 1 D), Oral. During the same period patient was treated with CARBAMAZEPINE (200 Mg (200 Mg, 1 In 1 D), Oral) (View Carbamazepine Review and Carbamazepine Label ), ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE (10 Mg/25 Mg (1 Dosage Forms, 1 In 1 D),oral) (View Enalapril Maleate And Hydrochlorothiazide Review and Enalapril Maleate And Hydrochlorothiazide Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6428517-9 | Atelectasis, Blood Albumin Decreased, Blood Thyroid Stimulating Hormone Increased, Breast Cancer Metastatic, Cough, Decreased Appetite, Dyspnoea, Hydronephrosis
Adverse event was reported on Oct 01, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: 8 Mg (8 Mg,1 In 1 D),oral) was diagnosed with pleural effusion, breast cancer (What is breast cancer?) and. Location: , 59 years of age, After Torsemide was administered, patient had the following side effects: atelectasis, blood albumin decreased, blood thyroid stimulating hormone increased, breast cancer metastatic, cough, decreased appetite, dyspnoea, hydronephrosis. During the same period patient was treated with SUNITINIB MALATE (SUNITINIBI MALATE) (37.5 Mg (37.5 Mg,1 In 1 D),oral) (View Sunitinib Malate (sunitinibi Malate) Review and Sunitinib Malate (sunitinibi Malate) Label ), GABAPENTIN (200 Mg (200 Mg,1 In 1 D),oral) (View Gabapentin Review and Gabapentin Label ), BROMHEXINE HYDROCHLORIDE (BROMHEXINE HYDROCHLORIDE) (View Bromhexine Hydrochloride (bromhexine Hydrochloride) Review and Bromhexine Hydrochloride (bromhexine Hydrochloride) Label ). Patient was hospitalized.

6424976-6 | Renal Failure Acute
on Nov 02, 2009 Male patient from UNITED STATES , 74 years of age, was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure acute. Torsemide dosage: 200 Mg Bid Po. During the same period patient was treated with METOLAZONE (5 Mg Other Po) (View Metolazone Review and Metolazone Label ). Patient was hospitalized.


6408790-3 | Dermatitis Exfoliative, Pruritus
on Oct 05, 2009 Male patient from , 88 years of age, was diagnosed with oedema peripheral and was treated with Torsemide (View Usage). Patient had the following side effects: dermatitis exfoliative, pruritus. Torsemide dosage: 4 Mg (4 Mg,1 In 1 D),oral. During the same period patient was treated with CARDENALIN (DOXAZOSIN MESYLATE) (View Cardenalin (doxazosin Mesylate) Review and Cardenalin (doxazosin Mesylate) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DIOVAN (View Diovan Review and Diovan Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), PRERAN (TARNDOLAPRIL) (View Preran (tarndolapril) Review and Preran (tarndolapril) Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ). Patient was hospitalized.

6404186-9 | Dermatitis Exfoliative, Eosinophil Count Increased
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: dermatitis exfoliative, eosinophil count increased on Sep 24, 2009 from Additional patient health information: Male patient , 88 years of age, was diagnosed with oedema peripheral and. Torsemide dosage: 4 Mg (4 Mg, 1 In 1 D), Oral. During the same period patient was treated with CARDENALIN (DOXAZOSIN MESYLATE) (View Cardenalin (doxazosin Mesylate) Review and Cardenalin (doxazosin Mesylate) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), DIOVAN (View Diovan Review and Diovan Label ), ITRACONAZOLE (View Itraconazole Review and Itraconazole Label ), TRANDOLAPRIL (View Trandolapril Review and Trandolapril Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), SELBEX (TEPRENONE) (View Selbex (teprenone) Review and Selbex (teprenone) Label ). Patient was hospitalized.

6404170-5 | Pancreatitis
Adverse event was reported on Sep 30, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral) was diagnosed with gastritis and. Location: , 75 years of age, Patient experienced the following unwanted or unexpected effects: pancreatitis. During the same period patient was treated with JANUVIA (100 Mg (100 Mg, 1 In 1 D), Oral) (View Januvia Review and Januvia Label ), DIOVAN (80 Mg (80 Mg, 1 In 1 D), Oral) (View Diovan Review and Diovan Label ), CRESTOR (10 Mg (10 Mg, 1 In 1 D), Oral) (View Crestor Review and Crestor Label ), NEXIUM (40 Mg (40 Mg, 1 In 1 D), Oral) (View Nexium Review and Nexium Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

6398620-0 | Abdominal Pain Upper, Angina Unstable, Arteriovenous Fistula Thrombosis, Atrial Fibrillation, Blood Creatine Increased, Blood Urea Increased, Bundle Branch Block Left, Cardiac Disorder, Cardiac Failure
on Jun 25, 2009 Male patient from , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Torsemide (View Usage). Patient had the following side effects: abdominal pain upper, angina unstable, arteriovenous fistula thrombosis, atrial fibrillation (What is atrial fibrillation?), blood creatine increased, blood urea increased, bundle branch block left, cardiac disorder, cardiac failure. Torsemide dosage: . During the same period patient was treated with SAXAGLIPTIN (SAXAGLIPTIN) ((2.5 Mg),oral) (View Saxagliptin (saxagliptin) Review and Saxagliptin (saxagliptin) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CARMEN (View Carmen Review and Carmen Label ), INSUMAN COMB 25(BIPHASIC) (Subcutaneous) (View Insuman Comb 25(biphasic) Review and Insuman Comb 25(biphasic) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6391656-5 | Arteriosclerosis, Asthenia, Back Pain, Bradycardia, Diarrhoea, Dyspnoea, Electrocardiogram Abnormal, Gait Disturbance, Haemodialysis
on Sep 25, 2009 Male patient from SWEDEN , 69 years of age, was diagnosed with essential hypertension and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: arteriosclerosis, asthenia, back pain (What is back pain?), bradycardia, diarrhoea, dyspnoea, electrocardiogram abnormal, gait disturbance, haemodialysis. Torsemide dosage: 30 Mg (30 Mg,1 In 1 D),oral. During the same period patient was treated with TILUR (ACEMETACIN) (2 Dosage Forms (1 Dosage Forms,2 In 1 D),oral) (View Tilur (acemetacin) Review and Tilur (acemetacin) Label ), DIOVAN (View Diovan Review and Diovan Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), INSULATARD (INSULIN HUMAN) (View Insulatard (insulin Human) Review and Insulatard (insulin Human) Label ), NEXIUM (View Nexium Review and Nexium Label ), SIMCORA (SIMVASTATIN) (View Simcora (simvastatin) Review and Simcora (simvastatin) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6383268-4 | Alcohol Use, Arthralgia, Cellulitis, Cutaneous Vasculitis, Dizziness, Hypersensitivity, Leukocytoclastic Vasculitis, Nausea, Osteomyelitis
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: alcohol use, arthralgia, cellulitis (What is cellulitis?), cutaneous vasculitis, dizziness (What is dizziness?), hypersensitivity, leukocytoclastic vasculitis, nausea (What is nausea?), osteomyelitis on Sep 07, 2009 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with cellulitis (What is cellulitis?), infection (What is infection?) and. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D). During the same period patient was treated with SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), CEFTRIAXON (View Ceftriaxon Review and Ceftriaxon Label ), VANCOMYCIN (Intravenous (not Otherwise Specified)) (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ). Patient was hospitalized.

6369638-9 | Fluid Retention
Adverse event was reported on Sep 09, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: 80 Mg; Qd; Po, 120 Mg; Qd; Po) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 83 years of age, weighting 205.0 lb, Patient had the following side effects: fluid retention. During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

6366258-7 | Chills, Demyelination, Depressed Level Of Consciousness, Gaze Palsy, Hypertonia, Myoclonus, Nephrogenic Diabetes Insipidus, Renal Failure Acute, Therapeutic Agent Toxicity
on Aug 31, 2009 Female patient from , 75 years of age, was diagnosed with cardiac failure, bipolar disorder (What is bipolar disorder?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: chills, demyelination, depressed level of consciousness, gaze palsy, hypertonia, myoclonus, nephrogenic diabetes insipidus, renal failure acute, therapeutic agent toxicity. Torsemide dosage: 20mg, Daily,unk. During the same period patient was treated with LITHIUM (660mg, Daily, Unk) (View Lithium Review and Lithium Label ), ENALAPRIL MALEATE (20mg-daily-unk) (View Enalapril Maleate Review and Enalapril Maleate Label ).

6361151-8 | Asthenia, Back Pain, Dizziness, Muscle Spasms, Somnolence, Vomiting
on Sep 16, 2009 Male patient from UNITED STATES , 84 years of age, weighting 142.0 lb, was diagnosed with fluid retention and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, back pain (What is back pain?), dizziness (What is dizziness?), muscle spasms, somnolence, vomiting. Torsemide dosage: One 100 Mg Daily. Patient was hospitalized.

6346726-4 | Platelet Count Decreased
Patient was taking Torsemide (View Usage). Patient had the following side effects: platelet count decreased on Jun 10, 2009 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with cardiac failure congestive, hypercholesterolaemia and. Torsemide dosage: 4 Mg (4 Mg,1 In 1 D),oral. During the same period patient was treated with LIPITOR (Oral) (View Lipitor Review and Lipitor Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), LAC B (LACTOBACILLUS ACIDOPHILUS, LYOPHILIZED) (View Lac-b (lactobacillus Acidophilus, Lyophilized) Review and Lac-b (lactobacillus Acidophilus, Lyophilized) Label ), FERROMIA (SODIUM FERROUS CITRATE) (View Ferromia (sodium Ferrous Citrate) Review and Ferromia (sodium Ferrous Citrate) Label ), MUCOSTA (REBAMIPIDE) (View Mucosta (rebamipide) Review and Mucosta (rebamipide) Label ), BROTIZOLAM (BROTIZOLAM) (View Brotizolam (brotizolam) Review and Brotizolam (brotizolam) Label ). Patient was hospitalized.

6342780-4 | Haemorrhagic Diathesis, Idiopathic Thrombocytopenic Purpura
Adverse event was reported on Aug 19, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: 4 Mg (4 Mg, 1 In 1 D)) was diagnosed with hyperlipidaemia and. Location: , 75 years of age, After Torsemide was administered, patient had the following side effects: haemorrhagic diathesis, idiopathic thrombocytopenic purpura. During the same period patient was treated with LIPITOR (5 Mg (5 Mg, 1 In 1 D)) (View Lipitor Review and Lipitor Label ), ALOSSENN (ACHILLEA, MADDER, SENNA, TARAXACUM OFFICINALE) (View Alossenn (achillea, Madder, Senna, Taraxacum Officinale) Review and Alossenn (achillea, Madder, Senna, Taraxacum Officinale) Label ). Patient was hospitalized.

6335834-X | Dehydration, Dialysis, Infection, Renal Failure Acute
on Aug 12, 2009 Male patient from SWITZERLAND , 82 years of age, was diagnosed with hypertensive heart disease, cryoglobulinaemia and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, dialysis (What is dialysis?), infection (What is infection?), renal failure acute. Torsemide dosage: 1 Dosage Forms (1 Dosage Forms,1 In 1 D),oral. During the same period patient was treated with RITUXIMAB (RITUXIMAB) (2 Dosage Forms (1 Dosage Forms,2 In 1 Total),intravenous (not Otherwise Specified)) (View Rituximab (rituximab) Review and Rituximab (rituximab) Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), NEXIUM (View Nexium Review and Nexium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ). Patient was hospitalized.

6329987-7 | Activated Partial Thromboplastin Time Shortened, Alveolitis, Anti-hbc Antibody Positive, Blood Potassium Decreased, Dyspnoea, Hepatitis, Pleurisy
on Aug 10, 2009 Female patient from GERMANY , 80 years of age, was diagnosed with hypertension, rheumatoid arthritis (What is rheumatoid arthritis?), tachyarrhythmia, hyperlipidaemia, restlessness, prophylaxis against gastrointestinal ulcer and was treated with Torsemide (View Usage). Patient had the following side effects: activated partial thromboplastin time shortened, alveolitis, anti-hbc antibody positive, blood potassium decreased, dyspnoea, hepatitis (What is hepatitis?), pleurisy. Torsemide dosage: 200 Mg (200 Mg, 1 In 1 D), Oral. During the same period patient was treated with METHOTREXATE SODIUM (1.4286 Milliliter (10 Milliliter, 1 In 1 Wk), Subcutaneous) (View Methotrexate Sodium Review and Methotrexate Sodium Label ), RAMIPRIL (2.5 Mg (2.5 Mg, 1 In 1 D), Oral) (View Ramipril Review and Ramipril Label ), FALITHROM (PHENPROCOUMON) (3 Mg (3 Mg, 1 In 1 D), Oral) (View Falithrom (phenprocoumon) Review and Falithrom (phenprocoumon) Label ), SIMVASTATIN (40 Mg (40 Mg, 1 In 1 D), Oral) (View Simvastatin Review and Simvastatin Label ), SEROQUEL (25 Mg (25 Mg, 1 In 1 D), Oral) (View Seroquel Review and Seroquel Label ), CORDANUM (TALINOLOL) (50 Mg (50 Mg, 1 In 1 D), Oral) (View Cordanum (talinolol) Review and Cordanum (talinolol) Label ), OMEPRAZOLE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Omeprazole Review and Omeprazole Label ), AMLODIPINE (5 Mg (5 Mg, 1 In 1 D), Oral) (View Amlodipine Review and Amlodipine Label ). Patient was hospitalized.

6326519-4 | Alanine Aminotransferase Increased, Anaemia, Blood Albumin Decreased, Blood Creatinine Increased, Blood Lactate Dehydrogenase Increased, Blood Urea Increased, Brain Natriuretic Peptide Increased, Cardiac Failure, Condition Aggravated
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: alanine aminotransferase increased, anaemia, blood albumin decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, brain natriuretic peptide increased, cardiac failure, condition aggravated on Jul 31, 2009 from Additional patient health information: Female patient , 69 years of age, was diagnosed with cardiac failure, mitral valve incompetence and. Torsemide dosage: 8 Mg (8 Mg, 1 In 1 D), Oral. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), MAGMITT (MAGNESIUM OXIDE) (View Magmitt (magnesium Oxide) Review and Magmitt (magnesium Oxide) Label ), WARFARIN (WARFARIN POTASSIUM) (View Warfarin (warfarin Potassium) Review and Warfarin (warfarin Potassium) Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6324392-1 | Activated Partial Thromboplastin Time Prolonged, Blood Glucose Increased, Gallbladder Enlargement, Gallbladder Non-functioning, Haemoglobin Decreased, International Normalised Ratio Increased, Pancreatitis Acute
Adverse event was reported on Aug 05, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: Oral) was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and. Location: GERMANY , 78 years of age, Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, blood glucose increased, gallbladder enlargement, gallbladder non-functioning, haemoglobin decreased, international normalised ratio increased, pancreatitis acute. During the same period patient was treated with FALITHROM (PHENPROCOUMON) (3 Mg (3 Mg, 1 In 1 D),oral) (View Falithrom (phenprocoumon) Review and Falithrom (phenprocoumon) Label ), DIOVAN HCT (40 Mg Valsartan/ 6.25 Mq Hctz (1 Dosage Forms, 1 In 1 D), Oral) (View Diovan Hct Review and Diovan Hct Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6309311-6 | Diabetes Insipidus, Disturbance In Attention, Eye Movement Disorder, Hypertonia, Hypotension, Myoclonus, Neurological Symptom, Pneumonia
on Jul 28, 2009 Male patient from GERMANY , 75 years of age, was diagnosed with cardiac failure, bipolar disorder (What is bipolar disorder?) and was treated with Torsemide (View Usage). Patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), disturbance in attention, eye movement disorder, hypertonia, hypotension, myoclonus, neurological symptom, pneumonia (What is pneumonia?). Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D). During the same period patient was treated with LITHIUM CARBONATE (660 Mg (330 Mg, 2 In 1 D)) (View Lithium Carbonate Review and Lithium Carbonate Label ), ENALAPRIL MALEATE (20 Mg (20 Mg, 1 In 1 D)) (View Enalapril Maleate Review and Enalapril Maleate Label ), ASPIRIN (100 Mg (100 Mg, 1 In 1 D)) (View Aspirin Review and Aspirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PREGABALIN (PREGABALIN) (View Pregabalin (pregabalin) Review and Pregabalin (pregabalin) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MACROGOL (MACROGOL) (View Macrogol (macrogol) Review and Macrogol (macrogol) Label ). Patient was hospitalized.

6308524-7 | Condition Aggravated, Metabolic Acidosis, Renal Failure Acute
on Jul 31, 2009 Male patient from SWITZERLAND , 72 years of age, was diagnosed with pain (What is pain?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: condition aggravated, metabolic acidosis, renal failure acute. Torsemide dosage: Oral. During the same period patient was treated with TILUR (ACEMETACIN) (Oral) (View Tilur (acemetacin) Review and Tilur (acemetacin) Label ). Patient was hospitalized.

6305610-2 | Blood Albumin Decreased, Blood Albumin Increased, Breast Cancer Female, Decreased Appetite, Malignant Neoplasm Progression, Neutrophil Count Decreased, Pain In Extremity, Pleural Effusion, Weight Decreased
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, blood albumin increased, breast cancer female, decreased appetite, malignant neoplasm progression, neutrophil count decreased, pain in extremity, pleural effusion, weight decreased on Jul 21, 2009 from Additional patient health information: Female patient , 58 years of age, was diagnosed with pleural effusion, breast cancer (What is breast cancer?) and. Torsemide dosage: 8 Mg (8 Mg, 1 In 1 D), Oral. During the same period patient was treated with SUNITINIB MALATE (SUNITINIB MALATE) (37.5 Mg (37.5 Mg, 1 In 1 D), Oral) (View Sunitinib Malate (sunitinib Malate) Review and Sunitinib Malate (sunitinib Malate) Label ), GABAPENTIN (200 Mg (200 Mg, 1 In 1 D), Oral) (View Gabapentin Review and Gabapentin Label ), BROMHEXINE HYDROCHLORIDE (BROMHEXINE HYDROCHLORIDE) (View Bromhexine Hydrochloride (bromhexine Hydrochloride) Review and Bromhexine Hydrochloride (bromhexine Hydrochloride) Label ). Patient was hospitalized.

6304214-5 | Pancreatitis Acute
Adverse event was reported on Aug 04, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: ) was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and. Location: GERMANY , 78 years of age, weighting 198.4 lb, Patient had the following side effects: pancreatitis acute. During the same period patient was treated with PHENPROCOUMON (View Phenprocoumon Review and Phenprocoumon Label ), DIOVAN HCT (40mg Valsartan + 6.25mg Hct) (View Diovan Hct Review and Diovan Hct Label ). Patient was hospitalized.

6295595-X | Atrial Fibrillation, Blood Potassium Increased, Blood Sodium Decreased, Dehydration, Dyslipidaemia, Gastroenteritis Viral, Haematocrit Decreased
on Jul 16, 2009 Male patient from GERMANY , 69 years of age, weighting 244.7 lb, was diagnosed with hypertension, pyelonephritis, atrial fibrillation (What is atrial fibrillation?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), blood potassium increased, blood sodium decreased, dehydration, dyslipidaemia, gastroenteritis viral, haematocrit decreased. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with CIPROFLOXACIN HCL (500 Mg (250 Mg, 2 In 1 D), Oral) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), LISIHEXAL COMP (LISINOPRIL, HYDROCHLOROTHIAAZIDE) (20/12.5 Mg (1 Tablet, 2 In 1 D), Oral) (View Lisihexal Comp (lisinopril, Hydrochlorothiaazide) Review and Lisihexal Comp (lisinopril, Hydrochlorothiaazide) Label ), DIGIMED (DIGITOXIN) (0.07 Mg (0.07 Mg, 1 In 1 D), Oral) (View Digimed (digitoxin) Review and Digimed (digitoxin) Label ), AGGRENOX (ACETYLLSALICYLIC ACID, DIPYRIDAMOLE) (View Aggrenox (acetyllsalicylic Acid, Dipyridamole) Review and Aggrenox (acetyllsalicylic Acid, Dipyridamole) Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VERA 80 HEUMANN (VERAPAMIL) (View Vera 80 Heumann (verapamil) Review and Vera 80 Heumann (verapamil) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6284919-5 | Blood Albumin Decreased, Cough, Decreased Appetite, Dyspnoea, Neutrophil Count Decreased, Pain In Extremity, Pleural Effusion, Thoracic Cavity Drainage, Weight Decreased
on Jul 10, 2009 Female patient from UNITED STATES , 58 years of age, was diagnosed with pleural effusion, breast cancer (What is breast cancer?) and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, cough, decreased appetite, dyspnoea, neutrophil count decreased, pain in extremity, pleural effusion, thoracic cavity drainage, weight decreased. Torsemide dosage: 8 Mg (8 Mg, 1 In 1 D), Oral. During the same period patient was treated with SUNITINIB MALATE (SUNITINIB MALATE) (37.5 Mg (37.5 Mg, 1 In 1 D), Oral) (View Sunitinib Malate (sunitinib Malate) Review and Sunitinib Malate (sunitinib Malate) Label ), GABAPENTIN (200 Mg (200 Mg, 1 In 1 D), Oral) (View Gabapentin Review and Gabapentin Label ), BROMHEXINE HYDROCHLORIDE (BROMHEXINE HYDROCHLORIDE) (View Bromhexine Hydrochloride (bromhexine Hydrochloride) Review and Bromhexine Hydrochloride (bromhexine Hydrochloride) Label ). Patient was hospitalized.

6284144-8 | Diabetes Insipidus, Disturbance In Attention, Eye Movement Disorder, Hypertonia, Myoclonus, Neurological Symptom, Pneumonia, Renal Failure Acute
Patient was taking Torsemide (View Usage). Patient had the following side effects: diabetes insipidus (What is diabetes insipidus?), disturbance in attention, eye movement disorder, hypertonia, myoclonus, neurological symptom, pneumonia (What is pneumonia?), renal failure acute on Jul 07, 2009 from Additional patient health information: Male patient , 75 years of age, was diagnosed with cardiac failure, bipolar disorder (What is bipolar disorder?) and. Torsemide dosage: 20 Mg (20 Mg, 1 In 1 D). During the same period patient was treated with LITHIUM CARBONATE (660 Mg (330 Mg, 2 In 1 D)) (View Lithium Carbonate Review and Lithium Carbonate Label ), ENALAPRIL MALEATE (20 Mg (20 Mg, 1 In 1 D)) (View Enalapril Maleate Review and Enalapril Maleate Label ), ASPIRIN (100 Mg (100 Mg, 1 In 1 D)) (View Aspirin Review and Aspirin Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PREGABALIN (PREGABALIN) (View Pregabalin (pregabalin) Review and Pregabalin (pregabalin) Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), MACROGOL (MACROGOL) (View Macrogol (macrogol) Review and Macrogol (macrogol) Label ). Patient was hospitalized.

6283214-8 | Diarrhoea, Renal Failure, Vomiting
Adverse event was reported on Jul 16, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: ) was diagnosed with hypertension, pyelonephritis, atrial fibrillation (What is atrial fibrillation?) and. Location: GERMANY , 69 years of age, weighting 244.7 lb, After Torsemide was administered, patient had the following side effects: diarrhoea, renal failure, vomiting. During the same period patient was treated with CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), DIGITOXIN TAB (View Digitoxin Tab Review and Digitoxin Tab Label ), LISINOPRIL AND HYDROCHLOROTHIAZIDE (40mg Lisinopril, 25mg Hct) (View Lisinopril And Hydrochlorothiazide Review and Lisinopril And Hydrochlorothiazide Label ). Patient was hospitalized.

6268072-X | Abdominal Pain Upper, Blood Creatinine Increased, Blood Urea Increased, Dizziness, Left Ventricular Failure, Loss Of Consciousness, Orthostatic Hypotension, Pleural Effusion, Pneumonia
on Jun 25, 2009 Male patient from , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, blood creatinine increased, blood urea increased, dizziness (What is dizziness?), left ventricular failure, loss of consciousness, orthostatic hypotension, pleural effusion, pneumonia (What is pneumonia?). Torsemide dosage: . During the same period patient was treated with SAXAGLIPTIN (2.5 Mg, Oral) (View Saxagliptin Review and Saxagliptin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CARMEN (View Carmen Review and Carmen Label ), INSUMAN COMB 25 (BIPHASIC) (Subcutaneous) (View Insuman Comb 25 (biphasic) Review and Insuman Comb 25 (biphasic) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6227386-X | Ascites, Condition Aggravated, Gallbladder Disorder, Hepatic Cirrhosis, Hepatomegaly, Hepatorenal Failure, Hypotension, Portal Hypertension
on May 25, 2009 Female patient from SPAIN , 71 years of age, was diagnosed with oedema peripheral and was treated with Torsemide (View Usage). Patient had the following side effects: ascites, condition aggravated, gallbladder disorder, hepatic cirrhosis, hepatomegaly, hepatorenal failure, hypotension, portal hypertension. Torsemide dosage: 80 Mg (80 Mg, 1 In 1 D), Oral. During the same period patient was treated with ALDACTONE (View Aldactone Review and Aldactone Label ), OMEPRAZOL (View Omeprazol Review and Omeprazol Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), EMPORTAL (LACTITOL) (View Emportal (lactitol) Review and Emportal (lactitol) Label ).

6213709-4 | Acute Prerenal Failure, Clonus, Depressed Level Of Consciousness, Diabetes Insipidus, Gaze Palsy, Glasgow Coma Scale Abnormal, Hyperkalaemia
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: acute prerenal failure, clonus, depressed level of consciousness, diabetes insipidus (What is diabetes insipidus?), gaze palsy, glasgow coma scale abnormal, hyperkalaemia on May 15, 2009 from SWITZERLAND Additional patient health information: Male patient , 75 years of age, was diagnosed with cardiac failure, affective disorder and. Torsemide dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with LITHIOFOR (POTASSIUM SULFATE) (660 Mg (330 Mg, 2 In 1 D), Oral) (View Lithiofor (potassium Sulfate) Review and Lithiofor (potassium Sulfate) Label ), ENALAPRIL MALEATE (20 Mg (20 Mg, 1 In 1 D), Oral) (View Enalapril Maleate Review and Enalapril Maleate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ), ASS MEPHA (ACETYLSALICYLIC ACID) (View Ass Mepha (acetylsalicylic Acid) Review and Ass Mepha (acetylsalicylic Acid) Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6211263-4 | Blood Potassium Decreased, Blood Sodium Decreased, Metabolic Alkalosis
Adverse event was reported on May 13, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: ;twice A Day; Oral) was diagnosed with cardiac failure, asthma (What is asthma?), hypereosinophilic syndrome and. Location: GERMANY , 51 years of age, weighting 202.8 lb, Patient experienced the following unwanted or unexpected effects: blood potassium decreased, blood sodium decreased, metabolic alkalosis. During the same period patient was treated with AQUAPHOR TABLET (NO PREF. NAME) (20 MG) (20 Mg; 1_null_day; Oral) (View Aquaphor Tablet (no Pref. Name) (20 Mg) Review and Aquaphor Tablet (no Pref. Name) (20 Mg) Label ), SALBUTAMOL (SALBUTAMOL) (100 UG) (View Salbutamol (salbutamol) (100 Ug) Review and Salbutamol (salbutamol) (100 Ug) Label ), PREDNISOLON (PREDNISOLONE) (30 MG) (30 Mg;1_null_day; Oral 15 Mg;) (View Prednisolon (prednisolone) (30 Mg) Review and Prednisolon (prednisolone) (30 Mg) Label ), AERIUS (View Aerius Review and Aerius Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FALITHROM (View Falithrom Review and Falithrom Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6204939-6 | Alanine Aminotransferase Increased, Anorexia, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Blood Bilirubin Unconjugated Increased, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Jaundice
on May 08, 2009 Female patient from JAPAN , 66 years of age, was diagnosed with atrial septal defect, diabetes mellitus, nasopharyngitis and was treated with Torsemide (View Usage). Patient had the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood bilirubin unconjugated increased, gamma-glutamyltransferase increased, hepatic function abnormal, jaundice (What is jaundice?). Torsemide dosage: Oral. During the same period patient was treated with AMARYL ((1 Mg),oral) (View Amaryl Review and Amaryl Label ), AMLODIPINE BESYLATE ((5 Mg)) (View Amlodipine Besylate Review and Amlodipine Besylate Label ), ASPIRIN ((100 Mg),oral) (View Aspirin Review and Aspirin Label ), KAIGEN KAZE ((2 Dosage Forms)) (View Kaigen Kaze Review and Kaigen Kaze Label ), SILECE (FLUNITRAZEPAM) (View Silece (flunitrazepam) Review and Silece (flunitrazepam) Label ). Patient was hospitalized.

6194283-8 | Abdominal Pain Upper, Blood Creatine Increased, Blood Pressure Diastolic Decreased, Blood Urea Increased, Bundle Branch Block Left, Cardiac Failure, Dizziness, Loss Of Consciousness, Orthostatic Hypotension
on May 01, 2009 Male patient from , 71 years of age, was diagnosed with type 2 diabetes mellitus and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: abdominal pain upper, blood creatine increased, blood pressure diastolic decreased, blood urea increased, bundle branch block left, cardiac failure, dizziness (What is dizziness?), loss of consciousness, orthostatic hypotension. Torsemide dosage: . During the same period patient was treated with SAXAGLIPTIN (SAXAGLIPTIN) ((2.5 Mg),oral) (View Saxagliptin (saxagliptin) Review and Saxagliptin (saxagliptin) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CARMEN (View Carmen Review and Carmen Label ), INSUMAN COMB 25 (BIPHASIC) (View Insuman Comb 25 (biphasic) Review and Insuman Comb 25 (biphasic) Label ), ISOPHANE INSULIN (INSULIN) (View Isophane Insulin (insulin) Review and Isophane Insulin (insulin) Label ). Patient was hospitalized.

6187694-8 | Abdominal Pain Upper, Angina Unstable, Atrial Fibrillation, Blood Creatinine Increased, Blood Urea Increased, Bundle Branch Block Left, Cardiac Disorder, Coronary Artery Disease, Diabetic Neuropathy
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, angina unstable, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, blood urea increased, bundle branch block left, cardiac disorder, coronary artery disease (What is coronary artery disease?), diabetic neuropathy on Apr 24, 2009 from Additional patient health information: Male patient , 71 years of age, was diagnosed with type 2 diabetes mellitus and. Torsemide dosage: . During the same period patient was treated with SAXAGLIPTIN ((2.5 Mg), Oral) (View Saxagliptin Review and Saxagliptin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), CARMEN (View Carmen Review and Carmen Label ), INSUMAN COMB 25 (BIPHASIC) (View Insuman Comb 25 (biphasic) Review and Insuman Comb 25 (biphasic) Label ), ISOPHANE INSULIN (INSULIN) (View Isophane Insulin (insulin) Review and Isophane Insulin (insulin) Label ). Patient was hospitalized.

6183270-1 | Cytomegalovirus Antibody Positive, Disorientation, Epstein-barr Virus Antibody Positive, Hepatic Cirrhosis, Portal Hypertension, Toxoplasma Serology Positive
Adverse event was reported on Apr 21, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: 2.5 Mg (2.5 Mg, 1 In 1 D), Oral) was diagnosed with hypertension and. Location: , 67 years of age, Patient had the following side effects: cytomegalovirus antibody positive, disorientation, epstein-barr virus antibody positive, hepatic cirrhosis, portal hypertension, toxoplasma serology positive. During the same period patient was treated with VALSARTAN (160 Mg (160 Mg, 1 In 1 D)) (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6183206-3 | Blood Potassium Decreased, Hypocalcaemia, Peripheral Sensory Neuropathy, Quadriparesis
on Apr 21, 2009 Female patient from SPAIN , 74 years of age, was diagnosed with hypertension and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: blood potassium decreased, hypocalcaemia, peripheral sensory neuropathy, quadriparesis. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), EUTIROX (LEVOTHYROXINE) (View Eutirox (levothyroxine) Review and Eutirox (levothyroxine) Label ), FOSITENS (FOSINOPRIL SODIUM) (View Fositens (fosinopril Sodium) Review and Fositens (fosinopril Sodium) Label ), INALADUO (FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE) (View Inaladuo (fluticasone Propionate, Salmeterol Xinafoate) Review and Inaladuo (fluticasone Propionate, Salmeterol Xinafoate) Label ), PORTELOS (STRONTIUM RANELATE) (View Portelos (strontium Ranelate) Review and Portelos (strontium Ranelate) Label ), SINGULAIR (View Singulair Review and Singulair Label ). Patient was hospitalized.

6168320-0 | Hypertension, Incorrect Dose Administered, Oedema, Product Quality Issue
on Apr 24, 2009 Female patient from UNITED STATES , 74 years of age, weighting 209.0 lb, was diagnosed with hypertension, oedema and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, incorrect dose administered, oedema, product quality issue. Torsemide dosage: 1 Po.

6165858-7 | Aortic Valve Incompetence, Blood Creatine Increased, Blood Urea Increased, Disturbance In Attention, Fall, Hyperthyroidism, Hypotension, Loss Of Consciousness
Patient was taking Torsemide (View Usage). Patient had the following side effects: aortic valve incompetence, blood creatine increased, blood urea increased, disturbance in attention, fall (What is fall?), hyperthyroidism, hypotension, loss of consciousness on Apr 06, 2009 from Additional patient health information: Female patient , 95 years of age, weighting 138.9 lb, was diagnosed with hypertension, coronary artery disease (What is coronary artery disease?), sleep disorder (What is sleep disorder?) and. Torsemide dosage: 5 Mg (5 Mg,1 In 1 D), Oral. During the same period patient was treated with AMLODIPINE (5 Mg (5 Mg,1 In 1 D), Oral) (View Amlodipine Review and Amlodipine Label ), MOLSICOR (MOLSIDOMINE) (8 Mg (8 Mg,1 In 1 D), Oral) (View Molsicor (molsidomine) Review and Molsicor (molsidomine) Label ), PENTAERYTHIRITOL TETRANITRATE TAB (160 Mg (80 Mg,2 In 1 D), Oral) (View Pentaerythiritol Tetranitrate Tab Review and Pentaerythiritol Tetranitrate Tab Label ), MELPERONE (MELPERONE) (12.5 Mg (12.5 Mg,12.5 Mg, At Night), Oral) (View Melperone (melperone) Review and Melperone (melperone) Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), METHIZOL (THIAMAZOLE) (View Methizol (thiamazole) Review and Methizol (thiamazole) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TEBONIN (GINKGO TREE LEAVES EXTRACT) (View Tebonin (ginkgo Tree Leaves Extract) Review and Tebonin (ginkgo Tree Leaves Extract) Label ). Patient was hospitalized.

6165684-9 | Atrioventricular Block First Degree, Bundle Branch Block Left, Condition Aggravated, Decreased Appetite, Dehydration, Pulmonary Congestion, Renal Failure Chronic
Adverse event was reported on Apr 06, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) . Location: SWITZERLAND , 98 years of age, After Torsemide was administered, patient had the following side effects: atrioventricular block first degree, bundle branch block left, condition aggravated, decreased appetite, dehydration, pulmonary congestion, renal failure chronic. During the same period patient was treated with DIGOXIN (1 Dosage Forms (1 Dosage Forms, 1 In 1 D), Oral) (View Digoxin Review and Digoxin Label ), ENATEC (ENALAPRIL) (10 Mg (10 Mg, 1 In 1 D), Oral) (View Enatec (enalapril) Review and Enatec (enalapril) Label ), PLAVIX (View Plavix Review and Plavix Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CORVATON (MOLSIDOMINE) (View Corvaton (molsidomine) Review and Corvaton (molsidomine) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), NITRODERM (View Nitroderm Review and Nitroderm Label ). Patient was hospitalized.

6162259-2 | Renal Failure
on Apr 02, 2009 Female patient from SWITZERLAND , 90 years of age, was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Torsemide dosage: 20 Mg (10 Mg, 2 In 1 D), Oral. During the same period patient was treated with BACTRIM (800 Mg, (400 Mg, 2 In 1 D), Oral) (View Bactrim Review and Bactrim Label ), ALDACTONE (12.5 Mg (12.5 Mg, 1 In 1 D), Oral) (View Aldactone Review and Aldactone Label ), VANCOMYCIN HCL (1000 Mg (250 Mg, 4 In 1 D)) (View Vancomycin Hcl Review and Vancomycin Hcl Label ), DAFALGIN (3 Gm (1 Gm, 3 In 1 D), Oral) (View Dafalgin Review and Dafalgin Label ), ENALAPRIL MALEATE (5 Mg (2.5 Mg, 2 In 1 D), Oral) (View Enalapril Maleate Review and Enalapril Maleate Label ), CO AMOXIN (2400 Mg (1200 Mg, 2 In 1 D), Intravenous Drip) (View Co Amoxin Review and Co Amoxin Label ), ZOLOFT (25 Mg, Oral) (View Zoloft Review and Zoloft Label ), TOLVON (MIANSERIN HYDROCHLORIDE) (View Tolvon (mianserin Hydrochloride) Review and Tolvon (mianserin Hydrochloride) Label ).

6160089-9 | Activated Partial Thromboplastin Time Prolonged, Atrial Fibrillation, Blood Creatinine Increased, Cardiac Failure, Electrolyte Depletion, Fall, Gamma-glutamyltransferase Increased, Haemoglobin Decreased
on Apr 03, 2009 Male patient from , 79 years of age, weighting 127.9 lb, was diagnosed with hypertension, cardiac failure and was treated with Torsemide (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, atrial fibrillation (What is atrial fibrillation?), blood creatinine increased, cardiac failure, electrolyte depletion, fall (What is fall?), gamma-glutamyltransferase increased, haemoglobin decreased. Torsemide dosage: 10 Mg (10 Mg,1 In 1 D),oral. During the same period patient was treated with XIPAMIDE (5 Mg (5 Mg,1 In 1 D),oral) (View Xipamide Review and Xipamide Label ), FALITHROM (Oral) (View Falithrom Review and Falithrom Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), METAMIZOL NATRIUM(METAMIZOLE SODIUM) (View Metamizol Natrium(metamizole Sodium) Review and Metamizol Natrium(metamizole Sodium) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ). Patient was hospitalized.

6159327-8 | Cardiac Failure, Diarrhoea, Fluid Intake Reduced, Pulse Absent, Renal Failure Acute
Patient was taking Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: cardiac failure, diarrhoea, fluid intake reduced, pulse absent, renal failure acute on Apr 01, 2009 from Additional patient health information: Female patient , 68 years of age, weighting 224.9 lb, was diagnosed with hypertension, cardiac failure and. Torsemide dosage: 10 Mg (10 Mg, 1 In 1 D), Oral. During the same period patient was treated with RAMICARD (10 Mg (10 Mg, 1 In 1 D), Oral) (View Ramicard Review and Ramicard Label ), SPIRONOLACTONE (25 Mg (25 Mg, 1 In 1 D), Oral) (View Spironolactone Review and Spironolactone Label ), XIPAMIDE (40 Mg (40 Mg, 1 In 1 D), Oral) (View Xipamide Review and Xipamide Label ), ACETYLSALICYLIC ACID (ACETYLSALICYLIC ACID) (View Acetylsalicylic Acid (acetylsalicylic Acid) Review and Acetylsalicylic Acid (acetylsalicylic Acid) Label ), ACTRAPID PENFIL (INSULIN HUMAN) (View Actrapid Penfil (insulin Human) Review and Actrapid Penfil (insulin Human) Label ), BISOBETA (BISOPROLOL FUMARATE) (View Bisobeta (bisoprolol Fumarate) Review and Bisobeta (bisoprolol Fumarate) Label ), DOLORMIN (IBUPROFEN SODIUM) (View Dolormin (ibuprofen Sodium) Review and Dolormin (ibuprofen Sodium) Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

6150475-5 | Aortic Valve Incompetence, Fall, Hypotension, Overdose, Syncope
Adverse event was reported on Mar 25, 2009 by a Female patient taking Torsemide (View Usage) (Dosage: 5 Mg (5 Mg, 1 In 1 D), Oral) was diagnosed with hypertension, coronary artery disease (What is coronary artery disease?), sleep disorder (What is sleep disorder?) and. Location: , 95 years of age, weighting 138.9 lb, Patient experienced the following unwanted or unexpected effects: aortic valve incompetence, fall (What is fall?), hypotension, overdose, syncope. During the same period patient was treated with AMLOBETA (5 Mg (5 Mg, 1 In 1 D), Oral) (View Amlobeta Review and Amlobeta Label ), MOLSICOR (8 Mg (8 Mg, 1 In 1 D), Oral) (View Molsicor Review and Molsicor Label ), PENTALONG (160 Mg (80 Mg, 2 In 1 D), Oral) (View Pentalong Review and Pentalong Label ), MELPERONE (12.5 Mg (12.5 Mg, 12.5 Mg, At Night), Oral) (View Melperone Review and Melperone Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), METHIZOL (THIAMAZOLE) (View Methizol (thiamazole) Review and Methizol (thiamazole) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TEBONIN (GINKO TREE LEAVES EXTRACT) (View Tebonin (ginko Tree Leaves Extract) Review and Tebonin (ginko Tree Leaves Extract) Label ). Patient was hospitalized.

6149229-5 | Anaemia, Electrocardiogram Qt Prolonged, Hyperglycaemia, Hyperlipidaemia, Hyperuricaemia, Hypokalaemia, Leukopenia, Malnutrition, Metabolic Disorder
on Mar 27, 2009 Female patient from SWITZERLAND , 75 years of age, was diagnosed with hypertension and was treated with Torsemide (View Usage). Patient had the following side effects: anaemia, electrocardiogram qt prolonged, hyperglycaemia, hyperlipidaemia, hyperuricaemia, hypokalaemia, leukopenia, malnutrition, metabolic disorder (What is metabolic disorder?). Torsemide dosage: 5 Mg (5 Mg, 1 In 1 D),oral. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), ASPIRIN CADIO (View Aspirin Cadio Review and Aspirin Cadio Label ), CORVATON RETARD (MOLSIDOMINE) (View Corvaton Retard (molsidomine) Review and Corvaton Retard (molsidomine) Label ). Patient was hospitalized.

6139517-0 | Anaemia, Epistaxis, Haemorrhage
on Mar 19, 2009 Male patient from GERMANY , 72 years of age, weighting 257.9 lb, was diagnosed with hypertension, type 2 diabetes mellitus, atrial fibrillation (What is atrial fibrillation?), hyperuricaemia, dyslipidaemia, coronary artery disease (What is coronary artery disease?) and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: anaemia, epistaxis, haemorrhage. Torsemide dosage: . During the same period patient was treated with INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ), HUMALOG (30/22/34 Iu Tid) (View Humalog Review and Humalog Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), AQUAPHOR (View Aquaphor Review and Aquaphor Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6132360-8 | Arrhythmia, Colitis, Deep Vein Thrombosis, Dehydration, Impaired Healing, Pulmonary Embolism
Patient was taking Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?), colitis, deep vein thrombosis (What is deep vein thrombosis?), dehydration, impaired healing, pulmonary embolism (What is pulmonary embolism?) on Mar 10, 2009 from GERMANY Additional patient health information: Male patient , 84 years of age, weighting 180.8 lb, was diagnosed with oedema peripheral, chronic obstructive pulmonary disease and. Torsemide dosage: 10 Mg (10 Mg, 1in 1 D), Oral. During the same period patient was treated with THEOPHYLLINE (500 Mg (250 Mg, 2 In 1 D), Oral) (View Theophylline Review and Theophylline Label ), TASMULOSIN (View Tasmulosin Review and Tasmulosin Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), MUCOFALK (PSYLLIUM HYDROPHILIC MUCILLOID) (View Mucofalk (psyllium Hydrophilic Mucilloid) Review and Mucofalk (psyllium Hydrophilic Mucilloid) Label ). Patient was hospitalized.

6131968-3 | Accidental Exposure, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Thyroid Stimulating Hormone Decreased, Blood Urea Increased, Dehydration, Haematocrit Decreased, Haemoglobin Decreased
Adverse event was reported on Mar 09, 2009 by a Male patient taking Torsemide (View Usage) (Dosage: 10 Mg (10 Mg, 1 In 1 D), Oral) was diagnosed with accidental exposure, hypertension and. Location: , 85 years of age, weighting 0.12 lb, Patient had the following side effects: accidental exposure, alanine aminotransferase increased, aspartate aminotransferase increased, blood thyroid stimulating hormone decreased, blood urea increased, dehydration, haematocrit decreased, haemoglobin decreased. During the same period patient was treated with RISPERIDONE (2 Mg (2 Mg, 1 In 1 D, Oral) (View Risperidone Review and Risperidone Label ), DIGITOXIN TAB (0.07 Mg (0.07 Mg, 1 In 1 D), Oral) (View Digitoxin Tab Review and Digitoxin Tab Label ), MELPERONE (50 Mg (50 Mg, 1 In 1 D), Oral) (View Melperone Review and Melperone Label ), METOPROLOL (25 Mg (25 Mg, 1 In 1 D), Oral) (View Metoprolol Review and Metoprolol Label ), PENTALONG (80 Mg (80 Mg, 1 In 1 D), Oral) (View Pentalong Review and Pentalong Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), KREON 2000 (PANCREATIN) (View Kreon 2000 (pancreatin) Review and Kreon 2000 (pancreatin) Label ), NOVALGIN (METAMIZOLE SODIUM MONOHYDRATE) (View Novalgin (metamizole Sodium Monohydrate) Review and Novalgin (metamizole Sodium Monohydrate) Label ).

6125473-8 | Venous Thrombosis
on Mar 13, 2009 Male patient from GERMANY , 84 years of age, weighting 180.8 lb, was diagnosed with oedema peripheral, chronic obstructive pulmonary disease and was treated with Torsemide (View Usage). After Torsemide was administered, patient had the following side effects: venous thrombosis. Torsemide dosage: 10 Mg, Qd, Oral. During the same period patient was treated with THEOPHYLLINE (250 Mg, Bid, Oral) (View Theophylline Review and Theophylline Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MUCOFALK (PSYLLIUM HYDROPHILIC MUCILLOID) (View Mucofalk (psyllium Hydrophilic Mucilloid) Review and Mucofalk (psyllium Hydrophilic Mucilloid) Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ). Patient was hospitalized.

6124218-5 | Abdominal Distension, International Normalised Ratio Increased, Stress
on Mar 05, 2009 Female patient from UNITED STATES , 43 years of age, weighting 144.2 lb, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Torsemide (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, international normalised ratio increased, stress (What is stress?). Torsemide dosage: 60 Mg, [40 Mg Every Morning And 20 Mg Ever Evening]). During the same period patient was treated with WARFARIN SODIUM (7.5 Mg, Daily (52.5 Mg Per Week)) (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

6121840-7 | Electrolyte Depletion, Prothrombin Time Prolonged
Patient was taking Torsemide (View Usage). Patient had the following side effects: electrolyte depletion, prothrombin time prolonged on Feb 26, 2009 from GERMANY Additional patient health information: Male patient , 79 years of age, weighting 127.9 lb, was diagnosed with hypertension, cardiac failure and. Torsemide dosage: 10 Mg; Daily; Oral. During the same period patient was treated with RAMIPRIL (1.25 Mg; Daily; Oral) (View Ramipril Review and Ramipril Label ), SPIRONOLACTONE (25 Mg; Daily; Oral) (View Spironolactone Review and Spironolactone Label ), FALITHROM (PHENPROCOUMON) (Oral) (View Falithrom (phenprocoumon) Review and Falithrom (phenprocoumon) Label ), XIPAMIDE (XIPAMIDE) (5 MG) (5 Mg; Daily; Oral) (View Xipamide (xipamide) (5 Mg) Review and Xipamide (xipamide) (5 Mg) Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), MITAMIZOL NATRIUM (View Mitamizol Natrium Review and Mitamizol Natrium Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.